Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xtandi
Xtandi
Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool
Wed, 01/29/14 - 05:46 pm
Medivation
Astellas
JNJ
Zytiga
Xtandi
prostate cancer
Medivation prostate cancer drug impresses in pre-chemo study
Yahoo/Reuters
Wed, 01/29/14 - 09:29 am
Medivation
prostate cancer
Xtandi
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Motley Fool
Thu, 01/23/14 - 08:22 am
JNJ
Zytiga
Medivation
Xtandi
prostate cancer
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
Here's Why Medivation Jumped Higher This Week
Motley Fool
Sat, 10/26/13 - 11:26 am
Medivation
Xtandi
prostate cancer
Can Xtandi Become the Go-To Prostate Drug?
Motley Fool
Sat, 09/21/13 - 10:29 am
Xtandi
prostate cancer
Medivation
Astellas
Dendreon: Crushed By JNJ/Medivation Or By Own Management?
Seeking Alpha
Mon, 09/9/13 - 05:19 pm
JNJ
Medivation
Dendreon
Provenge
Xtandi
Zytiga
prostate cancer
Breakthrough Prostate Cancer Treatment May Propel Medivation Into The Black
Forbes
Mon, 07/29/13 - 12:14 pm
prostate cancer
Medivation
Xtandi
Astellas Launches Xtandi in the UK
Yahoo/Zacks
Sat, 07/13/13 - 11:42 am
Astellas
Xtandi
prostate cancer
Astellas' Xtandi approved in EU for prostate cancer
Pharma Times, UK
Mon, 06/24/13 - 10:50 am
Astellas
Xtandi
prostate cancer
Europe
Medivation
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Astellas
Xtandi
Daiichi Sankyo
Japan
Takeda
prostate cancer
Medivation, Astellas Pharma provide update on Phase 3 PREVAIL
Yahoo/Fly on the Wall
Mon, 04/1/13 - 10:49 am
Astellas
Medivation
metastatic castration-resistant prostate cancer
prostate cancer
Xtandi
Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/6/13 - 09:49 am
prostate cancer
Zytiga
JNJ
Xtandi
Medivation
Astellas
Provenge
Dendreon
Jevtana
Sanofi
Medivation falls after analyst says Xtandi must overcome obstacles
The Fly on the Wall
Thu, 02/28/13 - 11:27 am
Medivation
Xtandi
prostate cancer
Johnson & Johnson's Pioneering Zytiga And Its Competitors
Seeking Alpha
Sun, 02/24/13 - 02:26 pm
Zytiga. ARN-509
Xtandi
prostate cancer
Medivation
JNJ
Astellas
Aragon
Tokai
Court rules against Medivation in fight with UCLA over cancer drug
Yahoo/Fly on the Wall
Mon, 12/24/12 - 10:40 am
Medivation
UCLA
Aragon
Xtandi
prostate cancer
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
After XTANDI's FDA Approval, Medivation Pulls Back
Seeking Alpha
Sat, 11/17/12 - 01:44 pm
Xtandi
Medivation
prostate cancer
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Xtandi
Zytiga
prostate cancer
JNJ
Medivation
Astellas
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »